Market Intelligence, Clinical Progress, and High-Purity Reagents for Neuropsychiatric and Circadian Rhythm Disorder Development.
TarMart Solution Ecosystem & Related Targets
Comprehensive reagent toolkit for ASMT drug discovery. Products include wild-type and mutant proteins for variant analysis.
| Component / Network | Product Description | Product Link |
|---|---|---|
| Antigen (WT & Mutant) | ASMT Recombinant Protein (WT & Disease-Associated Mutants) High purity (>95%), Endotoxin <1EU/ug. Sequence Verified. E. coli or HEK293 Expressed. |
View ASMT Products |
| Gene Delivery | ASMT Promise-ORF / Lentivirus Full-length ORF for stable cell line generation. |
View ASMT Products |
| Detection & Benchmark Ab | Anti-ASMT Recombinant Antibody / Biosimilar Control For western blot, ELISA, IHC, and enzymatic assay readout. |
View ASMT Products |
| Validator | ASMT siRNA Set For knockdown verification, specificity controls, and pathway modeling. |
View ASMT Products |
| Related Target A | AANAT (Serotonin N-Acetyltransferase) Upstream rate-limiting enzyme in melatonin synthesis. |
View AANAT Products |
| Related Target B | MTNR1A (Melatonin Receptor 1A) Downstream receptor for signaling evaluation. |
View MTNR1A Products |
| Related Target C | MTNR1B (Melatonin Receptor 1B) Additional downstream receptor for comprehensive pathway counter-screening. |
View MTNR1B Products |
Critical Assay Challenges & TarMart Advantage
| Critical Assay Challenge | The TarMart Advantage (Technical Spec) |
|---|---|
| Enzymatic Assay Stability & High-Throughput Screening | High-purity soluble ASMT preserving native folding and catalytic domains. Suitable for SAM-dependent HTS. |
| Methyltransferase Selectivity | Strictly sequence-verified protein panels for counter-screening against off-target methyltransferases (COMT, NNMT, etc.). |
| Lack of Reliable Controls | Sequence-verified recombinant benchmark antibodies and siRNA included for assay standardization and knockdown confirmation. |
| False Positives in Screening | Validated siRNA for precise baseline specificity checks in cellular models. |
| Structural Biology & Fragment Screening | Low-endotoxin, aggregation-controlled preparation suitable for crystallography, SPR, and BLI. |
Live ASMT R&D Tracker
Market data changes daily. Access the latest global pipeline status directly:
Global Clinical Landscape & Future Outlook
The race for ASMT (Acetylserotonin O-methyltransferase) therapeutics is evolving, with major players shifting focus from downstream receptor agonists to upstream endogenous pathway modulators. As an essential intracellular enzyme catalyzing the final step of melatonin biosynthesis, ASMT is increasingly implicated in autism spectrum disorders (ASD), severe depression, and profound circadian rhythm disruptions. As first-generation sleep therapies reach saturation, the next wave of R&D is targeting small molecule allosteric modulators and gene therapies designed to restore or enhance ASMT catalytic efficiency directly within the pineal gland and retina. Key mutations (e.g., rs121918819 with no effect on activity; rs17149149 nearly abolishing activity; rs121918823 reducing activity) provide critical validation points for therapeutic strategies.
Competitive Modality & Indication Snapshot
| Modality | Representative Players | Key Indications | Critical Assay Need (Why TarMart?) |
|---|---|---|---|
| Small Molecule Activators | Academic Consortia, Neuro-focused Biotechs | Autism Spectrum Disorder (ASD), Insomnia | Enzymatic HTS Assay (Need high-purity, sequence-verified recombinant protein) |
| Gene Therapy | Rare Disease Therapeutics Co. | Genetic ASMT Deficiency | Transduction Verification (Need Lentivirus and benchmark detection Abs) |
| Pathway Inhibitors | Translational Research Labs | Seasonal Affective Disorder | Selectivity Assay (Need wild-type proteins and off-target methyltransferase panels) |
| Chemical Probes / Tool Compounds | Structural Biology Consortia | Target Validation, Mechanism of Action | Binding & Structural Assay (Need crystallography-grade protein for SPR/X-ray) |